Navigation Links
QED International Associates Announces Changes to the HealthShares(TM) European Medical Products and Devices Index
Date:1/31/2008

NEW YORK, Jan. 31 /PRNewswire/ -- QED International Associates, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on Monday February 4, 2008, BioMerieux Worldwide (Euronext: BIM) will replace GYRUS GROUP PLC (GYG LN) in the HealthShares(TM) European Medical Products and Devices Index.

Companies that are included in The HealthShares(TM) European Medical Products and Devices Index are headquartered in Europe, quoted on at least one European Stock Exchange and are engaged in the research, development, manufacturing, distribution and/or commercialization of medical devices and/or products for the treatment or amelioration of human disorders and diseases.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com.


'/>"/>
SOURCE QED International Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mettler-Toledo International Inc. to Host Fourth-Quarter 2007 Earnings Conference Call
2. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
3. International consortium announces the 1000 Genomes Project
4. Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session
5. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
6. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
7. International Isotopes Inc. Names James Mayer as Chief Operating Officer
8. International brain aging expert challenges the existence of Alzheimers as a disease
9. EHE International Supports the American Liver Foundations Efforts at Raising Awareness for Hepatitis
10. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
11. International Sports Sciences Associations Ten Best Resolutions for Better Health in 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Marne, Michigan (PRWEB) , ... January 17, 2017 , ... January is National Stalking ... those who choose to lurk in the corners and commit the crime of stalking, a ... drug use and addiction, an often overlooked factor in stalking and other crimes. , “Stalking: ...
(Date:1/17/2017)... Illinois (PRWEB) , ... January 17, 2017 , ... For ... Breast Cancer Symposium (SABCS) or those who desire a more intimate review and analysis ... Breast Cancer – Bench to Bedside—is being offered by Imedex on February 4, 2017 ...
(Date:1/17/2017)... ... , ... Kevin Harrington (one of the original Sharks from mega-hit reality series ... topic of Beauty and Personal Care. , Everyone makes New Year’s ... commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro will ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting ... Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted ... providers. , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... A ... named winners of the fourth Cradle to Cradle Product Design Challenge , the ... fourth in a series of six circular design challenges scheduled to run through early ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
(Date:1/18/2017)... enero de 2017  Hoy, en el Foro Económico ... iniciativa global para avanzar el acceso a la prevención ... de renta baja y baja-media (LICs y LMICs). ... crisis, particularmente en países de renta baja y media, ... las muertes relacionadas con NCD. El objetivo de Access ...
(Date:1/18/2017)... -- With an annual growth ranging from 6% to 10%, South East Asia,s ... Expo, March 22-24, 2017) serves the industry by fostering the regional discourse - ... Investment Forum ASEAN -- India ... content Enhanced business matchmaking program Roadshows ... ...
Breaking Medicine Technology: